Paulness, You cannot really say for a FACT that CYGX has a cure until they have cured humans and they are not even in human clinical trials yet nor have they even submitted their IND application to date. We all know that what works in a lab in test tubes and on mice, doesn't always work on humans. CYGX has made many statements in the past that have not come to pass. That is why the street is not impressed with the PR's you posted. Hence the low price of the shares.
"If the facts don't fit the theory, change the facts."